Ab interno trabecular bypass surgery with Schlemm´s Canal Microstent (Hydrus) for open angle glaucoma
Referencias
Additional references
AGIS. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. American Journal of Ophthalmology 2000;130(4):429‐40.
Burr JM, Mowatt G, Hernandez R, Siddiqui MA, Cook J, Lourenco T, et al. The clinical effectiveness and cost‐effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. Health Technology Assessment 2007;11(41):1‐190.
CNTG Study Group. Comparison of glaucomatous progression between untreated patients with normal‐tension glaucoma and patients with therapeutically reduced intraocular pressures. American Journal of Ophthalmology 1998;126(4):487‐97.
Veritas Health Innovation. Covidence. Melbourne: Veritas Health Innovation, 2015.
Francis BA, Singh K, Lin SC, Hodapp E, Jampel HD, Samples JR, et al. Novel glaucoma procedures: a report by the American Academy of Ophthalmology. Ophthalmology 2011;118(7):1466‐80.
Friedman DS, Okeke CO, Jampel HD, Ying GS, Plyler RJ, Jiang Y, et al. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma. Ophthalmology 2009;116(6):1097‐105.
Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC, et al. Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow‐up. American Journal of Ophthalmology 2012;153(5):804‐14.
Glanville JM, Lefebvre C, Miles JN, Camosso‐Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130‐6.
GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed prior to 24 April 2017. Hamilton (ON): GRADE Working Group, McMaster University, 2014.
Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Archives of Ophthalmology 2002;120(10):1268‐79.
Higgins JP, Altman DG, Sterne JAC, editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Hu K, Gazzard G, Bunce C, Wormald R. Ab interno trabecular bypass surgery with Trabectome for open angle glaucoma. Cochrane Database of Systematic Reviews 2016, Issue 8. [DOI: 10.1002/14651858.CD011693.pub2]
Ismail R, Azuara‐Blanco A, Ramsay CR. Outcome measures in glaucoma: a systematic review of Cochrane reviews and protocols. Journal of Glaucoma 2015;24(7):533‐8.
Ismail R, Azuara‐Blanco A, Ramsay CR. Consensus on outcome measures for glaucoma effectiveness trials: results from a delphi and nominal group technique approaches. Journal of Glaucoma 2016;25(6):539‐46.
James Lind Alliance Sight Loss, Vision Priority Setting Partnership. Setting priorities for eye research. www.sightlosspsp.org.uk (accessed 10 June 2014).
Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open‐angle glaucoma. Archives of Ophthalmology 2002;120(6):701‐13.
King A, Azuara‐Blanco A, Tuulonen A. Glaucoma. BMJ 2013;346:f3518.
Kirwan JF, Lockwood AJ, Shah P, Macleod A, Broadway DC, King AJ, et al. Trabeculectomy in the 21st century: a multicenter analysis. Ophthalmology 2013;120(12):2532‐9.
Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001;108(11):1943‐53.
Mansberger SL, Gordon MO, Jampel H, Bhorade A, Brandt JD, Wilson B, et al. Reduction in intraocular pressure after cataract extraction: the Ocular Hypertension Treatment Study. Ophthalmology 2012;119(9):1826‐31.
Okeke CO, Quigley HA, Jampel HD, Ying GS, Plyler RJ, Jiang Y, et al. Adherence with topical glaucoma medication monitored electronically. The Travatan Dosing Aid study. Ophthalmology 2009;116(2):191‐9.
Overby DR, Stamer WD, Johnson M. The changing paradigm of outflow resistance generation: towards synergistic models of the JCT and inner wall endothelium. Experimental Eye Research 2009;88(4):656‐70.
Peters D, Bengtsson B, Heijl A. Lifetime risk of blindness in open‐angle glaucoma. American Journal of Ophthalmology 2013;156(4):724‐30.
Pfeiffer N, Garcia‐Feijoo J, Martinez‐de‐la‐Casa JM, Larrosa JM, Fea A, Lemij H, et al. A randomized trial of a Schlemm's Canal Microstent with phacoemulsification for reducing Intraocular pressure in open‐angle glaucoma. Ophthalmology 2015;122(7):1283‐93.
Piltz J, Gross R, Shin DH, Beiser JA, Dorr DA, Kass MA, et al. Contralateral effect of topical beta‐adrenergic antagonists in initial one‐eyed trials in the ocular hypertension treatment study. American Journal of Ophthalmology 2000;130(4):441‐53.
Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology 2006;90(3):262‐7.
Radcliffe NM, Musch DC, Niziol LM, Liebmann JM, Ritch R, Collaborative Initial Glaucoma Treatment Study Group. The effect of trabeculectomy on intraocular pressure of the untreated fellow eye in the collaborative initial glaucoma treatment study. Ophthalmology 2010;117(11):2055‐60.
Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
